Gaiser, M., Merx, K., Schulte, N., & Hofheinz, R. (2018). Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: A post hoc analysis of the EVITA trial. Annals of oncology, 29(12), . https://doi.org/10.1093/annonc/mdy451
Chicago Style (17th ed.) CitationGaiser, Maria, Kirsten Merx, Nadine Schulte, and Ralf-Dieter Hofheinz. "Vitamin K1 Cream Significantly Reduces Incidence and Severity of Cetuximab-related Acneiform Skin Rash in Women: A Post Hoc Analysis of the EVITA Trial." Annals of Oncology 29, no. 12 (2018). https://doi.org/10.1093/annonc/mdy451.
MLA (9th ed.) CitationGaiser, Maria, et al. "Vitamin K1 Cream Significantly Reduces Incidence and Severity of Cetuximab-related Acneiform Skin Rash in Women: A Post Hoc Analysis of the EVITA Trial." Annals of Oncology, vol. 29, no. 12, 2018, https://doi.org/10.1093/annonc/mdy451.